
|Videos|February 24, 2023
A Medical Oncologist’s Perspective on Cardiovascular Risk Assessment in Prostate Cancer
Medical oncologist Joelle Hamilton, MD, reflects on the prevalence of cardiovascular risk while managing prostate cancer in patients.
Advertisement
Episodes in this series

January 2023 AbbVie Inc. Company Confidential
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Focal therapy for prostate cancer frequently used outside guideline-supported groups
2
Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC
3
Published LITESPARK-011 data show PFS benefit with belzutifan plus lenvatinib in ccRCC
4
Active surveillance use for low-risk prostate cancer reaches 93% in VA System
5















